Peter Vorhees, MD, Director of Outreach and Clinical Operations, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, discusses GRIFFIN Trial Safety & Efficacy. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
